Specification: 28 tabs per box
Manufacturer: Boehringer Ingelheim
It is suitable for the treatment of advanced non-small cell lung cancer with EGFR gene mutation and advanced breast cancer with HER2 positive. Alfaatinib is an oral drug, an irreversible inhibitor of epidermal growth factor receptor (EGFR) and human epidermal receptor 2(HER2) tyrosine kinase, and a second-generation egfr-targeted drug.
It is suitable for the treatment of patients with advanced squamous cell carcinoma of lung during platinum chemotherapy or after chemotherapy.
We provide customers with quality products and services.
If you would like to leave us a comment please go to contact us